Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Axsome Thera (NQ: AXSM )

62.25 +1.70 (+2.81%)
Streaming Delayed Price Updated: 2:52 PM EDT, Mar 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Axsome Thera

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
These Were the Five Best And Worst Performing Mid-Cap Stocks In August 2022
We have used the August return data from finviz.com to come up with the five best and worst performing mid-cap stocks in August 2022. 
Via Talk Markets
7 Top-Rated Biotech Stocks to Buy for Q4
A new White House program makes these seven names some outstanding biotech stocks to buy for the fourth quarter. 
Via InvestorPlace
Biotech Stocks Stand to Benefit as Biden Announces Support for Industry
President Biden has announced a new initiative to help U.S. biotech producers grow. Here's what this news means for biotech stocks. 
Via InvestorPlace
Important Biotech Catalysts For September 8, 2022 - End Of The Day Summary
 
Via Benzinga
Mizuho Bolsters Price Target By 55% On This Migraine Stock
 
Via Benzinga
Analyst Ratings for Axsome Therapeutics
Within the last quarter, Axsome Therapeutics (NASDAQ:AXSM) has observed the following analyst ratings: 
Via Benzinga
Expert Ratings for Axsome Therapeutics
Within the last quarter, Axsome Therapeutics (NASDAQ:AXSM) has observed the following analyst ratings: 
Via Benzinga
Boxed Warnings May Not Hinder This Depression Drug's Broad Market Penetration, Analyst Says
 
Via Benzinga
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
 
Via Benzinga
Axsome Therapeutics Commences Late-Stage Migraine Study
Axsome Therapeutics (NASDAQ: AXSM) has enrolled the first patient in the EMERGE trial of its lead candidate AXS-07 for the acute treatment of migraine. 
Via Benzinga
Bluebird bio Seeks Back-to-Back Nods, 'Go' or 'No-Go' For Revance's Botox Rival, Amylyx' Twin Hurdles And More: September's Key PDUFA Catalysts Biotech Investors Must Know
After August’s mixed tally for Food and Drug Administration approvals, investors turn to a new month, which has a fairly loaded calendar. 
Via Benzinga
HC Wainwright Boosts Price Target On This Stock By 167%, Plus B of A Securities Predicts $40 For This Online Travel Stock
HC Wainwright & Co. raised the price target for Rockwell Medical, Inc. (NASDAQ: RMTI) from $3 to $8. Rockwell Medical shares rose 0.7% to close at $1.42 on Monday. 
Via Benzinga
$1000 Invested In Axsome Therapeutics 5 Years Ago Would Be Worth This Much Today
Axsome Therapeutics (NASDAQ:AXSM) has outperformed the market over the past 5 years by 57.38% on an annualized basis producing an average annual return of 67.54%. Currently, Axsome Therapeutics has a... 
Via Benzinga
10 Biotech Stocks Are Up 40% Or More This Year, Including Karuna, Axsome And Others
These names are benefitting from M&A, clinical data and promising regulatory actions. 
Via Investor's Business Daily
AMC Entertainment Price Target Cut By This Analyst, Plus DA Davidson Predicts $318 For Estée Lauder
DA Davidson cut the price target for The Estée Lauder Companies Inc. (NYSE: EL) from $342 to $318. Estée Lauder shares fell 0.4% to $264.29 in pre-market trading. 
Via Benzinga
Netflix Price Target Cut By This Analyst, Plus Morgan Stanley Predicts $403 For McKesson
UBS cut the price target for Coupa Software Incorporated (NASDAQ: COUP) from $84 to $76. Coupa Software shares fell 4.9% to $64.44 in pre-market trading. 
Via Benzinga
Why GigaCloud Technology Jumped 206%; Here Are 79 Biggest Movers From Yesterday
Gainers GigaCloud Technology Inc (NASDAQ: GCT) shares jumped 206% to close at $48.01 on Friday on continued volatility following the company's IPO on Thursday. 
Via Benzinga
Stocks That Made New Highs On Friday, Aug. 19
On Friday, in spite of the stock market being down, there were several stocks that actually made new highs. 
Via Talk Markets
Recap Of Friday's Biotech Catalysts - End Of the Day Summary
 
Via Benzinga
S&P 500 Down More Than 1%; Bed Bath & Beyond Shares Plummet
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping over 250 points on Friday. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
  
Via Benzinga
Axsome Therapeutics Rockets After Winning FDA Approval For A New Depression Drug
Axsome's drug targets a neurotransmitter believed to play a role in depression. 
Via Investor's Business Daily
Why Bed Bath & Beyond Is Trading Lower By Over 40%, Here Are 55 Stocks Moving In Friday's Mid-Day Session
Gainers GigaCloud Technology Inc (NASDAQ: GCT) shares jumped 145% to $38.45 on continued volatility following the company's IPO on Thursday. 
Via Benzinga
How Is The Market Feeling About Axsome Therapeutics?
Axsome Therapeutics's (NASDAQ:AXSM) short percent of float has fallen 3.86% since its last report. The company recently reported that it has 5.75 million shares sold short, which... 
Via Benzinga
Nasdaq Dips 250 Points; Crude Oil Moves Higher
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping around 250 points on Friday. 
Via Benzinga
Here's How Much You Would Have Made Owning Axsome Therapeutics Stock In The Last 5 Years
Axsome Therapeutics (NASDAQ:AXSM) has outperformed the market over the past 5 years by 52.74% on an annualized basis producing an average annual return of 64.23%. Currently, Axsome Therapeutics has a... 
Via Benzinga
General Motors, Foot Locker And Some Other Big Stocks Recording Gains On Friday
  GigaCloud Technology Inc (NASDAQ: GCT) shares jumped 145% to $38.45 on continued volatility following the company's IPO on Thursday. 
Via Benzinga
GCT Stock Alert: What Is Going on With GigaCloud Technology Today?
GigaCloud Technology (GCT) stock is continuing to rally on Friday after the Hong Kong-based fintech company launched its IPO yesterday. 
Via InvestorPlace
Why Is Volcon (VLCN) Stock Up 56% Today?
Volcon (VLCN) stock is rocketing higher on Friday after the EV company revealed massive pre-production orders for its Stag. 
Via InvestorPlace
Dow Falls Over 200 Points; Deere Earnings Miss Estimates
U.S. stocks traded lower this morning, with the Dow Jones dropping more than 200 points on Friday. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.